EnviroMap® is a comprehensive software solution that allows you to automate your environmental monitoring program.

This secure web-based system is transforming environmental monitoring across the food industry, providing users effortless systematic tracking and traceability. EnviroMap® assists with the entire sampling life cycle, from scheduling all the way to historical data analysis.


Automated Scheduling

Set up recurring, on demand, and / or mitigation collections in the system. All collections are color coded based on progression through the sampling process. Print barcodes, submit samples, and review results all from user specific, customizable dashboard.

Notification System

Various levels of real-time notification are available for Tests, Tasks and Results based on predetermined parameters defined by the customer.


Once a positive or out-of-limit result has been confirmed, mitigation collections will automatically appear on the calendar. Analysts can begin the resampling process based on parameters outlined by your organization. A parent-child relationship will exist between the original out-of-spec site and subsequent mitigations illustrating track and traceability. 

MXNS Integration

EnviroMap® allows for the seamless integration with Mérieux NutriSciences’ LIMS and myMXNS. The Electronic Data Interchange (EDI) platform provides a bi-directional interface between EnviroMap® and LIMS. EnviroMap® automatically propagates the required fields in LIMS and results are exported back to EnviroMap® providing complete traceability and historical analysis. 

Historical Analysis

Flexible and easy to use reporting tools to present, analyze, and share results. Numerous reporting options including Grids, Maps, Bar Charts, Pie Charts, Line Graphs, and Summary Reports.

Mérieux NutriSciences is not just a promoter of EnviroMap, we are also a proud user and customer!

August 7th, 2019
according to IEC 62366-1:2015 and IECIEC/TR 62366-2:2016 One of the main reasons of medical device recalled are usability issues. Medical devices fault caused by design, packaging/labelling, user o...
July 25th, 2019
Press Release , Local News
On July 3rd 2019, Valbiotis announced positive results from the Phase IIA clinical study of VALEDIA®, now the first product proven effective on people suffering from dysglycemia. We ...